16 Nov 2021 Research

John Goldman Fellowships for 2022 open in December

Leukaemia UK is delighted to announce that we are funding more ground-breaking research in 2022, by continuing our investment in early career scientists and clinicians for our prestigious John Goldman Fellowships.

Applications for the annual fellowship programme open on 1st December 2021 to scientists and clinician-scientists working in UK universities, research institutions or hospitals. There is no age limit, although the fellowship programme is designed to provide funding at a critical point in a researcher’s career – the transition to becoming an independent researcher.

We have now increased the maximum award available to £150,000, to span a minimum 18-month and maximum 2-year period.

The John Goldman Fellowships were created in honour of Professor John Goldman (1938 – 2013), a renowned haematologist and pioneer in the treatment of leukaemia.

The awards are aimed at early career researchers with a passion for science, a desire to develop new ideas and translate scientific advances into clinical practice.

Successful applicants will show that they are the potential scientific/clinical leaders of the future. Their proposed research project must be novel with the capacity to make advances in our knowledge of leukaemia and related diseases and the development of new and kinder treatments.

Find out more about the 2021 John Goldman Fellows and their research projects:

Dr Daniel Coleman- AML: Developing kinder treatments by targeting mutated RAS

Dr Pramila Krishnamurthy – Understanding how donor lymphocyte infusion can prevent leukaemia patients from relapsing after a stem cell transplant

Dr Samanta Mariani – Investigating the role of macrophages in infant leukaemia

Dr William Grey (pictured above) – Could targeting the repertoire of proteins in AML lead to improved survival for the most at risk patients?

Dr Giulia Orlando (pictured right) – The role of RAS in Juvenile Myelomonocytic Leukaemia-finding new therapies?

Applications for the 2022 fellowships close on 31st January 2022. Find out more about the application process.

Related posts

Leukaemia UK appoints new CEO

27 August 2020

Leukaemia UK appoints new CEO

The trustees of Leukaemia UK are delighted to announce that they have appointed Fiona Hazell as CEO of Leukaemia UK. Fiona brings a strong track record in not-for-profit leadership, starting her role on 9th September 2020.

Inquiry highlights the impact of COVID-19 on blood cancer services

11 March 2022

Inquiry highlights the impact of COVID-19 on blood cancer services

A new report has recently been published, following an inquiry by the All-Party Parliamentary Group (APPG) on Blood Cancer and the APPG on Stem Cell Transplantation and Advanced Cellular Therapies, on the impact of Covid-19 on blood cancer services in the UK.

Trailblazing research project announced to exploit novel weaknesses in one of the least survivable cancers

21 April 2023

Trailblazing research project announced to exploit novel weaknesses in one of the least survivable cancers

A pioneering new study hopes to accelerate progress towards a new treatment for acute myeloid leukaemia (AML) in research announced today on World AML Day by Leukaemia UK.   University of…

Leukaemia UK and Leuka have merged

11 January 2019

Leukaemia UK and Leuka have merged

We are delighted to announce that on 1 November Leuka and Leukaemia UK merged